Semaglutide is a GLP-1 receptor agonist that works by mimicking a naturally occurring hormone involved in appetite regulation, gastric emptying, and blood sugar control
Effects on classic cardiovascular risk factors CVOTs on GLP-1RAs Data from the major CVOTs ELIXA, SUSTAIN-6, EXSCEL, HARMONY, PIONEER 6, LEADER, REWIND, and AMPLITUDE-O [53, 54, 56, 59,60,61,62,63] support the overall safety of GLP-1RAs relative to major cardiovascular outcomes
Benefits of Mounjaro in type 2 diabetes Mounjaro has demonstrated some of the most powerful glucose-lowering effects seen in modern diabetes treatment
Typically administered as a once-weekly injection, semaglutide GLP-1 offers a convenient and efficient treatment schedule
These alterations usually revert to normal over a few weeks to months
W., Harskamp, C